WEAVER LABS LLC — Department of Health and Human Services SBIR Phase I: R
WEAVER LABS LLC — SBIR Phase I award from Department of Health and Human Services.
- Amount
- $167,999
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase I
- Topic
- R
- Solicitation
- PA19-272
- NAICS
- —
- Place of performance
- OK
- Period
- 2021-04-01 → 2022-09-30
Description
AbstractPolyfluoro- and perfluoroalkyl substances (PFAS) are a group of highly fluorinated alkanes. Members of this family are known to be persistent and bioaccumulative. PFAS are associated with unfavorable health outcomes in human and animal models. Several public health agencies as well as scientists have published articles that indicate the presence of PFAS in human blood, serum, milk, cord blood, and tissues. Currently, detection of about a dozen of these chemicals out of more than a thousand of this class is performed using LCMS/MS. However, prior to analysis many purification steps are required to eliminate interfering species. Furthermore, the necessity of internal standards for the detection of PFAS, and the lack of pertinent internal standards dramatically reduces the scope of PFAS-detection. Currently, PFAS testing is a lengthy and costly undertaking that represents a major scientific bottleneck. Thus, there is an urgent need for a real-time detection technology that can sense a broad range of PFAS without pretreatment of sample, or expensive instrumentation. Implementation of such a product will allow better understanding of the fate of PFAS within the environment and their impact on human health.This proposal’s objective is to develop the pre-treatment free detection of PFAS in environmental matrices by coupling the key fluorous phase property with a highly sensitive fluorescence technology. In phase 1, we will apply the specific fluorous-fluorous interaction strategy to provide the adequate selectivity to preclude any associated purification steps. Fluorous tethered fluorescent dyes will be covalently immobilized on a glass surface. Initially, prior to exposure to PFAS, these fluorescent dyes will exist as excimers resulting from their close proximity to each other, the fluorescent probe turns the fluorescence on. Upon exposure to PFAS analytes, the analytes will be sequestered to the fluorous region of the probe due to specific fluorous-fluorous affinity. This will cause a physical disruption of the excimers, resulting in the fluorescence turn off of the excimer and a simultaneous turn on of the monomer emission. To achieve the proposed goal, in phase I the following specific aims will be pursued: specific aim1: 1) attachment of the fluorescent dye to the fluorous molecule, 2) immobilization of fluorous-dye array on glass surface, and 3) evaluation of fluorescence on-off of fluorous-dye glass surface with PFAS-samples. Ultimately the approach developed here will lay the groundwork for the development of a product that is expected to enable a broad range of researchers to study many types of effects on human health caused by PFAS.Project Narrative Rapid detection and quantification of PFAS is an immediate need for better understanding their properties such as their partition in different environmental matrices, health risks, exposure routes, fate and transportation, etc. In order to drive advancement of such study a novel approach will be applied for generation of chip-based PFAS sensors that can rapidly detect and quantify a broad range of PFAS in environmental matrices such as ground water, surface water, soil, etc. This technique is eventually expected to lead to a portable device that can enable the generation of bountiful information that will facilitate regulatory decision making, monitoring of PFAS sources, and ultimately reducing future exposures that benefit society.